- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01589588
Administration of Oxygen to Cluster Headache Patients
October 9, 2015 updated by: Mads Barløse
This study will investigate the possible difference in treatment effect between three different oxygen delivery systems in the acute treatment of cluster headaches.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Glostrup, Denmark, 2600
- Danish Headache Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- episodic cluster headache
- regular occurance of attacks and cluster for 2 years
- 2-8 attacks / day
- cluster periods of over 14 days
- duration of current cluster period max 14 days
- ability to differentiate between attacks of CH and other forms of headache
Exclusion Criteria:
- Changes in prophylactic treatment a week before trial
- pregnancy or breastfeeding women
- serious somatic or psychiatric disease
- COLD
- chronic or primary or secondary headache > 14 days / month other than CH
- alcohol abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mask 1
|
Mask type 1 oxygen
|
|
Experimental: Mask 2
|
Mask type 2 with oxygen
|
|
Experimental: Mask 3
|
Mask type 3 oxygen
mask type 3 oxygen
mask type 3 placebo
|
|
Placebo Comparator: Mask 3, placebo
|
mask type 3 oxygen
mask type 3 placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy
Time Frame: 15 minutes
|
Pain relief after 15 minutes of treatment
|
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mask preference
Time Frame: 2 days
|
subject mask preference
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
April 26, 2012
First Submitted That Met QC Criteria
April 30, 2012
First Posted (Estimate)
May 2, 2012
Study Record Updates
Last Update Posted (Estimate)
October 12, 2015
Last Update Submitted That Met QC Criteria
October 9, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2-2011-163
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cluster Headache Attacks
-
Diamond Headache ClinicGlaxoSmithKlineUnknownEpisodic Cluster Headache | Chronic Cluster HeadacheUnited States
-
Eli Lilly and CompanyCompletedEpisodic Cluster Headache | Chronic Cluster HeadacheSpain, United States, Finland, Germany, United Kingdom, Belgium, France, Denmark, Italy, Netherlands, Canada, Greece
-
Salvia BioElectronicsActive, not recruitingChronic Cluster HeadacheAustralia
-
Salvia BioElectronicsRecruitingChronic Cluster HeadacheNetherlands
-
Winston LaboratoriesNot yet recruitingEpisodic Cluster Headache
-
Leiden University Medical CenterNot yet recruiting
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Cluster HeadacheUnited States, Australia, Canada, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
-
Eli Lilly and CompanyCompletedChronic Cluster HeadacheUnited States, Germany, France, Canada, Belgium, Denmark, Finland, Greece, Italy, Netherlands, Spain, United Kingdom
-
University of Roma La SapienzaCompletedChronic Cluster HeadacheItaly
-
University of LiegeCompletedChronic Cluster HeadacheBelgium
Clinical Trials on Open Hudson Mask
-
Papworth Hospital NHS Foundation TrustCompletedCardiac SurgeryUnited Kingdom
-
Cancer Research AntwerpRecruitingHead and Neck NeoplasmBelgium
-
Irish Research Radiation Oncology GroupRecruiting
-
Dartmouth-Hitchcock Medical CenterCompletedRespiratory Distress Syndrome in Premature Infant
-
Laval UniversityNot yet recruitingRespiratory Failure | Oxygen Toxicity | COPD BronchitisCanada
-
Inonu UniversityCompletedRespiratory Distress Syndrome, NewbornTurkey
-
ResMedCompletedObstructive Sleep ApneaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCOPD Exacerbation | Acute Respiratory Failure | Hypercapnia | Hypoventilation Obesity SyndromeFrance
-
Riphah International UniversityCompletedHealthy VolunteersPakistan
-
University of AarhusRehalerCompletedHyperventilation | Dysfunctional Breathing | Chronic Idiopathic Hyperventilation | Respiratory AlkalosisDenmark